Literature DB >> 29094327

Reduced light sensitivity due to impaired retinal perfusion in branch retinal vein occlusion.

Hiroyuki Iijima1.   

Abstract

PURPOSE: To study the reduction in light sensitivity in areas where impaired retinal perfusion was established by fluorescein angiogram (FA) in eyes with branch retinal vein occlusion (BRVO) that recovered from retinal edema and hemorrhage.
DESIGN: Retrospective observational case series.
METHODS: A study of the reduction in light sensitivity demonstrated by total deviation display of the Humphrey perimetry program 30-2 in 43 eyes from 42 patients with BRVO, whose perfusion status was assessed by FA images taken at least 6 months after disease onset. Each of the 15 retinal squares in the FA images, corresponding to the 15 Humphrey test points around the fixation point in the affected vertical hemisphere, was classified as either perfused, partially perfused, or non-perfused. Correlation between light sensitivity and perfusion status was investigated by three evaluators in a total of 645 squares, 15 squares from each of the 43 subject eyes.
RESULTS: In 459 retinal squares (71.2%) with complete agreement on the perfusion status among the three evaluators, light sensitivity was significantly different among retinal squares of perfused (median: - 4.0 dB, n = 258), partially perfused (median: - 8.0 dB, n = 41), and non-perfused (median: - 16.0 dB, n = 160) (P < .000001, Kruskal-Wallis test).
CONCLUSIONS: Light sensitivity is decreased in retinal areas exhibiting impaired perfusion, likely due to neuronal loss in the inner retinal layer in eyes with chronic BRVO.

Entities:  

Keywords:  Branch retinal vein occlusion; Fluorescein angiogram; Humphrey perimetry; Light sensitivity; Perfusion

Mesh:

Year:  2017        PMID: 29094327     DOI: 10.1007/s10384-017-0546-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  10 in total

1.  Perimetric sensitivity and retinal thickness in eyes with macular edema resulting from branch retinal vein occlusion.

Authors:  M Imasawa; H Iijima; T Morimoto
Journal:  Am J Ophthalmol       Date:  2001-01       Impact factor: 5.258

2.  Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion.

Authors:  Noritatsu Yamaike; Mihori Kita; Akitaka Tsujikawa; Kazuaki Miyamoto; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2006-10-17       Impact factor: 5.258

3.  Sectoral thinning of the retina after branch retinal artery occlusion.

Authors:  Hiroshi Takahashi; Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

4.  Prediction of Retinal Ischemia in Branch Retinal Vein Occlusion: Spectral-Domain Optical Coherence Tomography Study.

Authors:  Hyung-Bin Lim; Min-Sun Kim; Young-Joon Jo; Jung-Yeul Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

5.  Influence of retinal ischemia on macular function after pars plana vitrectomy for macular edema with branch retinal vein occlusion.

Authors:  Hidetaka Noma; Katsunori Shimada; Tatsuya Mimura
Journal:  Int Ophthalmol       Date:  2013-03-29       Impact factor: 2.031

6.  Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment.

Authors:  Yasuhiro Iesato; Akira Imai; Takao Hirano; Yuichi Toriyama; Toshinori Murata
Journal:  Jpn J Ophthalmol       Date:  2016-01-22       Impact factor: 2.447

7.  Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.

Authors:  Ramin Tadayoni; Sebastian M Waldstein; Francesco Boscia; Heinrich Gerding; Ian Pearce; Siegfried Priglinger; Andreas Wenzel; Elizabeth Barnes; Margarita Gekkieva; Stefan Pilz; Jordi Monés
Journal:  Ophthalmology       Date:  2016-03-30       Impact factor: 12.079

8.  Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1986-01

9.  Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.

Authors:  W Lloyd Clark; David S Boyer; Jeffrey S Heier; David M Brown; Julia A Haller; Robert Vitti; Husain Kazmi; Alyson J Berliner; Kristine Erickson; Karen W Chu; Yuhwen Soo; Yenchieh Cheng; Peter A Campochiaro
Journal:  Ophthalmology       Date:  2015-10-30       Impact factor: 12.079

10.  Retinal sensitivity loss and structural disturbance in areas of capillary nonperfusion of eyes with diabetic retinopathy.

Authors:  Noriyuki Unoki; Kazuaki Nishijima; Atsushi Sakamoto; Mihori Kita; Daisuke Watanabe; Masanori Hangai; Tetsushi Kimura; Naoaki Kawagoe; Masahumi Ohta; Nagahisa Yoshimura
Journal:  Am J Ophthalmol       Date:  2007-09-14       Impact factor: 5.258

  10 in total
  4 in total

1.  Current practice in the management of branch retinal vein occlusion in Japan: Survey results of retina specialists in Japan.

Authors:  Yuichiro Ogura; Mineo Kondo; Kazuaki Kadonosono; Masahiko Shimura; Motohiro Kamei; Akitaka Tsujikawa
Journal:  Jpn J Ophthalmol       Date:  2019-08-19       Impact factor: 2.447

2.  Extended field imaging using swept-source optical coherence tomography angiography in retinal vein occlusion.

Authors:  Shinji Kakihara; Takao Hirano; Yasuhiro Iesato; Akira Imai; Yuichi Toriyama; Toshinori Murata
Journal:  Jpn J Ophthalmol       Date:  2018-03-28       Impact factor: 2.447

Review 3.  Mechanisms of vision loss in eyes with macular edema associated with retinal vein occlusion.

Authors:  Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2018-03-23       Impact factor: 2.447

4.  Left-Right and Upper-Lower Light Sensitivity Asymmetry in Visual Field Defects Caused by Pituitary Adenoma: A Retrospective Observational Study.

Authors:  Yumi Kotoda; Masakazu Kotoda; Masakazu Ogiwara; Hiroyuki Kinouchi; Hiroyuki Iijima
Journal:  Clin Ophthalmol       Date:  2020-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.